home.aspx

 
.

USING REAL-WORLD EVIDENCE FOR U.S. REGULATORY DECISION-MAKING: WHAT PHARMA NEEDS TO KNOW

SHARESHARESHARE
We are entering a new era in which real-world evidence is transforming how drugs are developed, approved, and commercialized. As FDA leads the change with a 3-year strategy—the Framework for FDA’s Real-World Evidence Program—the industry is launched on a shared learning process to understand where and when RWE can support regulatory decision-making. This webcast brings together industry experts in research and pharma to explore how forward-thinking pharmaceutical organizations are adopting new approaches for the use of RWE in drug development and approval.